NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OsteoCure Therapeutics

OsteoCure Therapeutics

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://osteocuretx.com/

Last Round

Accelerator

May 27, 2026

Total Funding Raised

$700,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OsteoCure Therapeutics is a biotechnology company that develops adenosine-based therapeutics to restore skeletal health, reverse bone loss, and accelerate bone repair.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

bone regenerationbiotechnologybiomaterialsorthobiologicsorthopedic surgeryosteoporosis treatmentdrug deliveryregenerative medicinefracture repairmedical devicesbone graftpain managementhydrogelbone healthbiotech startupopioid-sparing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OsteoCure Therapeutics Comparables

Compare OsteoCure Therapeutics with similar companies based on industry and business-model similarity.

OsteoCure Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Moroxite F
77%
Bone Solutions, Inc.
77%
Skeletalis Bio
71%

OsteoCure Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 27, 2026
AcceleratorApr 16, 2026
AcceleratorOct 20, 2025
AcceleratorMay 13, 2025
DebtNov 1, 2024

Key People

Founding team and executive leadership

Hunter Newman

Co-Founder and CEO

Founding Team

OsteoCure Therapeutics Investors

Notable investors and investment history

OsteoCure Therapeutics investors
InvestorRounds
Plug and Play Tech CenterAccelerator
MedTech InnovatorAccelerator
SCbioDriveAccelerator
North Carolina Biotechnology CenterDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Received funding from MedTech Innovator.

  • Nov 1, 2024

    $350K debt round completed.

OsteoCure Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OsteoCure Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OsteoCure Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range4
Year Founded2023
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.